MET and hepatocellular carcinoma: Therefore, the defective HGF/MET signaling observed upon C3G down-regulation might, at least, partially explain the reduced proliferation and survival of cells from HCC tumors bearing low levels of C3G, taking into account that Hep3B and HLE cells overexpress MET (Figure S7).